Sudeep Sodhi, MD
Gastroenterology · Menasha, WINPI 1679567606
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,242 of the $3,267 with a category attached, or 68.6%. 11 manufacturers reported payments, led by Boston Scientific at 57.3% of the total. 2025 is the largest year on record at $1,989, more than ten times the $72 reported in 2019.
Across 30 payments — averaging $108.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Olympus Corporation Of The Americas$664
- AbbVie$207
- Sanofi$115
- Gilead$107
- Phathom Pharmaceuticals, Inc.$96
- plus $205 from 5 others
What the payments were for
- Travel & lodging$2,24269%
- Food & beverage$97530%
- Education$502%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $1,872 |
| Olympus Corporation Of The Americas | 4 | $664 |
| AbbVie | 5 | $207 |
| Sanofi | 1 | $115 |
| Gilead | 1 | $107 |
| Phathom Pharmaceuticals, Inc. | 1 | $96 |
| Endogastric Solutions, Inc | 1 | $83 |
| Johnson & Johnson | 4 | $65 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Pfizer | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPYGLASS$1,632
- HANAROSTENT Esophagus TTS(CCC)$575
- Single Use Biliary Balloon Dilator$409
- Rinvoq$125
- DUPIXENT$115
- Livdelzi$107
How this compares
$3,267 in reported general payments places this provider in the 80th percentile of 285 gastroenterology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 37 | $326,432 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 822 | $17,979 |
| PentasaMesalamine | 12 | $17,585 |
| Mesalamine ErMesalamine | 18 | $9,140 |
| Ursodiol | 15 | $6,005 |
| Balsalazide Disodium | 20 | $4,130 |
| Mercaptopurine | 29 | $3,245 |
| Omeprazole | 124 | $1,527 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 72 | $1,511 |
| Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg | 34 | $708 |
| Pantoprazole Sodium | 42 | $558 |
| Azathioprine | 19 | $421 |
| Famotidine | 15 | $190 |
| Ondansetron Hcl | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Menasha
- Sankalp DwivediMenasha$5K
- Daniel SteinMilwaukee$227K
- Amir PatelSheboygan$137K
- Poonam Beniwal-PatelMilwaukee$108K
- Lilani PereraMequon$95K
- Freddy CalderaMadison$72K
- Matthew PellerMilwaukee$63K
- Susan LepinskiMadison$61K
- Chetan MittalMilwaukee$53K
- Pedro Palacios ArguetaEau Claire$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.